Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication
Status:
Unknown status
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
The investigators aimed to assess the effect of probiotic supplementation with Vigiis 101-LAB
during H. pylori eradication therapy with 14-day sequential therapy in the reduction of
adverse effects and the restoration of the dysbiosis.